Skip to main content
Clinical Trials/NCT05932745
NCT05932745RecruitingNot Applicable

Examining Appeal and Addiction Potential of Novel E-cigarette Constituents Among Adults

Yale University2 sites in 1 country66 target enrollmentStarted: June 20, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
66
Locations
2
Primary Endpoint
Liking: Score change in liking/wanting of each e-cigarette condition (5 conditions in total)

Study Overview

Brief Summary

This study is an examination of the influence of cooling components of WS-3, WS-23, and menthol on the appeal and addiction potential of nicotine-containing e-liquids among adults.

Detailed Description

The investigators will examine the influence of cooling components of WS-3, WS-23 (synthetic coolants) and menthol on the appeal and addiction potential of nicotine-containing e-liquids among adults. Participants will rate the flavor intensity, coolness, sweetness, and irritation/harshness, bitterness experienced using validated rating scales. 66 adult participants (18+ years of age) who are current e-cigarette users will participate in 3 laboratory sessions. Participants will be randomized to receive one of the 3 menthol conditions (no-menthol, low menthol, high menthol) in Lab 1 and will receive the alternative conditions in randomized order in Lab 2 and Lab 3. During each lab session the menthol condition will be paired with three WS-3 concentrations: no WS-3, low (0.1%) WS-3, or high (2.0%) WS-3 and three WS-23 concentrations: low (0.1%) WS-23, high (2.0%) WS-23, or 4% WS-23 in randomized order. All e-cigarettes will contain nicotine salt at a nicotine concentration of ~59mg/ml and all participants will be exposed to eighteen conditions across 3 lab sessions.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Other
Masking
Triple (Participant, Care Provider, Investigator)

Masking Description

Participants will be given a nicotine containing e-cigarette that could have various levels of cooling flavoring. Participants will not be told the nicotine concentration of the product or the type or concentration of the added coolant or what order it is presented in. Investigator and research assistant (i.e. care provider) will know the doses of nicotine and coolant, but will not know what order coolants are presented to participants.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18 years or older
  • Able to read and write
  • Some current e-cigarette use
  • Urine cotinine ≥200ng/ml
  • Willing to abstain from tobacco/nicotine use 2 hours prior to sessions

Exclusion Criteria

  • Current use of non-prescription substances besides nicotine, marijuana, alcohol
  • Any significant current medical or psychiatric condition
  • Known hypersensitivity to propylene glycol
  • Pregnant or lactating females
  • Uncontrolled asthma
  • Nut/e-liquid flavorant allergy
  • Current marijuana (tetrahydrocannabinol) vaping + E-cigarette or vaping use Associated Lung Injury (EVALI) symptoms
  • Dislike of menthol flavor

Arms & Interventions

Non-menthol, nicotine 59mg/ml (1)

Experimental

Flavor without menthol with 59mg/ml nicotine

Intervention: E-liquid coolant (No WS-3) for non-menthol (1) (Other)

Low (0.1%) menthol, nicotine 59mg/ml (1)

Experimental

Flavor with low menthol concentration with 59mg/ml nicotine

Intervention: E-liquid coolant (No WS-3) for low (0.1%) menthol (1) (Other)

High (2.0%) menthol, nicotine 59mg/ml (1)

Experimental

Flavor with high menthol concentration with 59mg/ml nicotine

Intervention: E-liquid coolant (No WS-3) for high (2.0%) menthol (1) (Other)

Non-menthol, nicotine 59mg/ml (2)

Experimental

Flavor without menthol with 59mg/ml nicotine

Intervention: E-liquid coolant (Low [0.1%] WS-3) for non-menthol (2) (Other)

Low (0.1%) menthol, nicotine 59mg/ml (2)

Experimental

Flavor with low menthol concentration with 59mg/ml nicotine

Intervention: E-liquid coolant (Low [0.1%] WS-3) for low (0.1%) menthol (2) (Other)

High (2.0%) menthol, nicotine 59mg/ml (2)

Experimental

Flavor with high menthol concentration with 59mg/ml nicotine

Intervention: E-liquid coolant (Low [0.1%] WS-3) for high (2.0%) menthol (2) (Other)

Non-menthol, nicotine 59mg/ml (3)

Experimental

Flavor without menthol with 59mg/ml nicotine

Intervention: E-liquid coolant (High [2.0%] WS-3) for non-menthol (3) (Other)

Low (0.1%) menthol, nicotine 59mg/ml (3)

Experimental

Flavor with low menthol concentration with 59mg/ml nicotine

Intervention: E-liquid coolant (High [2.0%] WS-3) for low (0.1%) menthol (3) (Other)

High (2.0%) menthol, nicotine 59mg/ml (3)

Experimental

Flavor with high menthol concentration with 59mg/ml nicotine

Intervention: E-liquid coolant (High [2.0%] WS-3) for high (2.0%) menthol (3) (Other)

Non-menthol, nicotine 59mg/ml (4)

Experimental

Flavor without menthol with 59mg/ml nicotine

Intervention: E-liquid coolant (Low [0.1%] WS-23) for non-menthol (4) (Other)

Low (0.1%) menthol, nicotine 59mg/ml (4)

Experimental

Flavor low menthol concentration with 59mg/ml nicotine

Intervention: E-liquid coolant (Low [0.1%] WS-23) for low (0.1%) menthol (4) (Other)

High (2.0%) menthol, nicotine 59mg/ml (4)

Experimental

Flavor high menthol concentration with 59mg/ml nicotine

Intervention: E-liquid coolant (Low [0.1%] WS-23) for high (2.0%) menthol (4) (Other)

Non-menthol, nicotine 59mg/ml (5)

Experimental

Flavor without menthol with 59mg/ml nicotine

Intervention: E-liquid coolant (High [2.0%] WS-23) for non-menthol (5) (Other)

Low (0.1%) menthol, nicotine 59mg/ml (5)

Experimental

Flavor low menthol concentration with 59mg/ml nicotine

Intervention: E-liquid coolant (High [2.0%] WS-23) for low (0.1%) menthol (5) (Other)

High (2.0%) menthol, nicotine 59mg/ml (5)

Experimental

Flavor high menthol concentration with 59mg/ml nicotine

Intervention: E-liquid coolant (High [2.0%] WS-23) for high (2.0%) menthol (5) (Other)

Non-menthol, nicotine 59mg/ml (6)

Experimental

Flavor without menthol with 59mg/ml nicotine

Intervention: E-liquid coolant (4% WS-23) for non-menthol (6) (Other)

Low (0.1%) menthol, nicotine 59mg/ml (6)

Experimental

Flavor low menthol concentration with 59mg/ml nicotine

Intervention: E-liquid coolant (4% WS-23) for low (0.1%) menthol (6) (Other)

High (2.0%) menthol, nicotine 59mg/ml (6)

Experimental

Flavor high menthol concentration with 59mg/ml nicotine

Intervention: E-liquid coolant (4% WS-23) for high (2.0%) menthol (6) (Other)

Outcomes

Primary Outcomes

Liking: Score change in liking/wanting of each e-cigarette condition (5 conditions in total)

Time Frame: Following administration of e-cigarette condition 1 (at 10 minutes), following administration of e-cigarette condition 2 (at 40 minutes)...following administration of e-cigarette condition 6 (at 160 minutes)

The Labeled Hedonic Scale will be used to ask about liking and wanting of the e-cigarette (one item Visual Analog Scale with ratings ranging from "most disliked sensation imaginable" to "most liked sensation imaginable" with higher values indicating greater liking).

Reinforcing Efficacy: Score change in drug effects of each e-cigarette condition (5 conditions in total)

Time Frame: Following administration of e-cigarette condition 1 (at 10 minutes), following administration of e-cigarette condition 2 (at 40 minutes)...following administration of e-cigarette condition 6 (at 160 minutes)

Difference between e-cigarette effects for each e-cigarette condition as measured by the computerized version of the Drug Effects Questionnaire (DEQ). Participants will self-report their responses using a computer mouse to indicate where on the scale response falls. A modified version of the Drug Effects Questionnaire (DEQ) will be used in which participants rate acute responses to the e-cigarette on a 0-100mm scale from "not at all" (0mm) to "extremely" (100mm).

Irritation/Harshness: Score change in irritation of harshness of each e-cigarette condition (5 conditions in total)

Time Frame: Following administration of e-cigarette condition 1 (at 10 minutes), following administration of e-cigarette condition 2 (at 40 minutes)...following administration of e-cigarette condition 6 (at 160 minutes)

Difference in irritation at each e-cigarette condition as measured by the computerized Generalized Labeled Magnitude Scale (gLMS). Participants will self-report their responses using a computer mouse to indicate where on the scale response falls. The Generalized Labeled Magnitude Scales (gLMS) are category ratio scales with seven semantic labels: "no sensation", "barely detectable", "weak", "moderate", "strong", "very strong", and "strongest imaginable", positioned quasi-logarithmically as per empirically determined semantic magnitudes on a 0-100 scale (strongest imaginable at the 100 end).

Secondary Outcomes

  • Craving: Change in craving score for e-cigarette from baseline at each e-cigarette condition (5 conditions in total)(At baseline (at 0 minute), following administration of e-cigarette condition 1 (at 10 minutes), following administration of e-cigarette condition 2 (at 40 minutes)...following administration of e-cigarette condition 6 (at 160 minutes))
  • Changes of salivary Nicotine and Cotinine Levels from baseline at each e-cigarette condition (6 conditions in total)(At baseline (at 0 minute), Following administration of e-cigarette condition 1 (at 10 minutes), following administration of e-cigarette condition 2 (at 40 minutes)...following administration of e-cigarette condition 6 (at 160 minutes))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials